Press Releases - 2023-02-03

Date	Title	Company
03-Feb-2023	Medidata Experts Present New Insights on Risk-Based Quality Management, Decentralized Clinical Trials, and Real World Data at SCOPE Summit	Businesswire
03-Feb-2023	Asia Pacific Cell & Gene Research Growing 50% Faster than ROW	Novotech, Asia Pacific CRO
03-Feb-2023	IV Poles Market is expected to reach US$ 306.1 Million by the end of 2029	MARKITWIRED
03-Feb-2023	Eye Tracking System Market is projected to register a high CAGR of 26.6% through 2028	MARKITWIRED
03-Feb-2023	Ibuprofen API Market is estimated to progress at a CAGR of 3% through 2029	MARKITWIRED
03-Feb-2023	Vacuum Blood Collection Devices Market is expected to reach US$ 4.2 Billion by 2031	MARKITWIRED
03-Feb-2023	Needle-Free Injectors Market to expand at a 12% value CAGR by 2032	MARKITWIRED
03-Feb-2023	Manometry Systems Market is expected to register a CAGR of 5.4% through 2031	MARKITWIRED
03-Feb-2023	Promotions and Team Expansion Mark the Start of a New Year at Leason Ellis	Businesswire
03-Feb-2023	FOXO Technologies Appoints Taylor Fay as Chief Operating Officer	Businesswire
03-Feb-2023	Former NFL standout, Rob Sims, and Pro Football Hall of Fame Member, Calvin Johnson Jr., Launch Primitiv Performance™ Line of nano-CBD Products	Businesswire
03-Feb-2023	Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials	Businesswire
03-Feb-2023	Ambrx Biopharma Strengthens Clinical Leadership with Appointment of Sandra Aung, Ph.D. as Head of Clinical Development	Businesswire
03-Feb-2023	New Talk About It Resources Aim to Accelerate Integration of Mental Health into Quality Cancer Care	Businesswire
03-Feb-2023	Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Therapy for Advanced or Recurrent Endometrial Carcinoma	Businesswire
03-Feb-2023	KalVista Pharmaceuticals to Present at SVB Securities Global Biopharma Conference	Businesswire
03-Feb-2023	IMFINZI (DURVALUMAB) IN COMBINATION WITH GEMCITABINE AND CISPLATIN APPROVED IN GREAT BRITAIN AS A FIRST-LINE TREATMENT FOR ADULT PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC BILIARY TRACT CANCER	AstraZeneca
03-Feb-2023	Tezspire approved for self-administration in the US with a new pre-filled pen	AstraZeneca
03-Feb-2023	CAS and Torx Software collaborate to streamline and accelerate small molecule discovery and design	Torx Software
03-Feb-2023	AC Immune to Present at the SVB Securities Global Biopharma Conference	AC Immune